Hudson Frederick M., a director at Supernus Pharmaceuticals (SUPN), made one open market sale of company shares in the last year, totaling about $315 thousand. His most recent sale occurred on August 14, 2025. This places him 7,436th out of 11,678 insiders by sales value, compared to an average of $8.6 million across about 6.4 transactions per insider. He had no open market purchases during this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 12, 2026 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Hudson Frederick M. | Director | S | Common Stock | 5369 | $50.61 | 60,413.0000 | 56,552,741 | 8.16% | 0.01% |
| Feb. 24, 2026 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Hudson Frederick M. | Director | D | Restricted Stock Unit | 4475 | $0.00 | 0.0000 | 56,552,741 | 100.00% | 0.01% |
| Feb. 24, 2026 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Hudson Frederick M. | Director | A | Common Stock | 4475 | $0.00 | 65,782.0000 | 56,552,741 | 7.30% | 0.01% |
| Feb. 18, 2026 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Hudson Frederick M. | Director | A | Director Stock Option (Right to Buy) | 4977 | $0.00 | 4,977.0000 | 56,552,741 | 9999.99% | 0.01% |
| Feb. 18, 2026 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Hudson Frederick M. | Director | A | Restricted Stock Unit | 2989 | $0.00 | 2,989.0000 | 56,552,741 | 9999.99% | 0.01% |
| Jan. 9, 2026 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Hudson Frederick M. | Director | M | Director Stock Option (Right to Buy) | 15000 | $0.00 | 0.0000 | 56,552,741 | 100.00% | 0.03% |
| Jan. 9, 2026 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Hudson Frederick M. | Director | M | Common Stock | 15000 | $12.98 | 61,307.0000 | 56,552,741 | 32.39% | 0.03% |
| Oct. 7, 2025 | scPharmaceuticals Inc. | $SCPH | Hudson Frederick M. | Not found | D | Stock Option (Right to Buy) | 30000 | $0.00 | 0.0000 | 53,719,662 | 100.00% | 0.06% |
| Oct. 7, 2025 | scPharmaceuticals Inc. | $SCPH | Hudson Frederick M. | Not found | D | Stock Option (Right to Buy) | 16300 | $0.00 | 0.0000 | 53,719,662 | 100.00% | 0.03% |
| Oct. 7, 2025 | scPharmaceuticals Inc. | $SCPH | Hudson Frederick M. | Not found | D | Stock Option (Right to Buy) | 19750 | $0.00 | 0.0000 | 53,719,662 | 100.00% | 0.04% |
| Oct. 7, 2025 | scPharmaceuticals Inc. | $SCPH | Hudson Frederick M. | Not found | D | Stock Option (Right to Buy) | 6124 | $0.00 | 0.0000 | 53,719,662 | 100.00% | 0.01% |
| Aug. 14, 2025 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Hudson Frederick M. | Director | S | Common Stock | 7457 | $42.26 | 46,307.0000 | 55,958,537 | 13.87% | 0.01% |
| June 3, 2025 | scPharmaceuticals Inc. | $SCPH | Hudson Frederick M. | Not found | A | Stock Option (Right to Buy) | 30000 | $0.00 | 30,000.0000 | 44,519,669 | 9999.99% | 0.07% |
| Feb. 22, 2025 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Hudson Frederick M. | Director | D | Restricted Stock Units | 5369 | $0.00 | 0.0000 | 55,958,537 | 100.00% | 0.01% |
| Feb. 22, 2025 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Hudson Frederick M. | Director | A | Common Stock | 5369 | $0.00 | 53,764.0000 | 55,958,537 | 11.09% | 0.01% |
| Feb. 19, 2025 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Hudson Frederick M. | Director | A | Director Stock Option (Right to Buy) | 7296 | $0.00 | 7,296.0000 | 55,958,537 | 9999.99% | 0.01% |
| Feb. 19, 2025 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Hudson Frederick M. | Director | A | Restricted Stock Unit | 4475 | $0.00 | 4,475.0000 | 55,958,537 | 9999.99% | 0.01% |
| Jan. 22, 2025 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Hudson Frederick M. | Director | M | Director Stock Option (Right to Buy) | 20000 | $0.00 | 0.0000 | 55,958,537 | 100.00% | 0.04% |
| Jan. 22, 2025 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Hudson Frederick M. | Director | M | Common Stock | 20000 | $9.13 | 48,395.0000 | 55,958,537 | 70.43% | 0.04% |
| Nov. 8, 2024 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Hudson Frederick M. | Director | S | Common Stock | 8722 | $36.28 | 28,395.0000 | 56,016,350 | 23.50% | 0.02% |
| June 11, 2024 | scPharmaceuticals Inc. | $SCPH | Hudson Frederick M. | Not found | A | Stock Option (Right to Buy) | 19750 | $0.00 | 19,750.0000 | 38,513,747 | 9999.99% | 0.05% |
| Feb. 23, 2024 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Hudson Frederick M. | Director | D | Restricted Stock Unit | 3886 | $0.00 | 0.0000 | 55,506,828 | 100.00% | 0.01% |
| Feb. 23, 2024 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Hudson Frederick M. | Director | A | Common Stock | 3886 | $0.00 | 37,117.0000 | 55,506,828 | 11.69% | 0.01% |
| Feb. 22, 2024 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Hudson Frederick M. | Director | A | Restricted Stock Units | 5369 | $0.00 | 5,369.0000 | 55,506,828 | 9999.99% | 0.01% |
| Feb. 22, 2024 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Hudson Frederick M. | Director | A | Director Stock Option (Right to Buy) | 8252 | $0.00 | 8,252.0000 | 55,506,828 | 9999.99% | 0.01% |
| Nov. 15, 2023 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Hudson Frederick M. | Director | M | Common Stock | 7457 | $9.24 | 42,324.0000 | 61,679,800 | 21.39% | 0.01% |
| Nov. 15, 2023 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Hudson Frederick M. | Director | M | Director Stock Option (Right to Buy) | 7457 | $0.00 | 0.0000 | 61,679,800 | 100.00% | 0.01% |
| Nov. 15, 2023 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Hudson Frederick M. | Director | S | Common Stock | 3882 | $28.50 | 38,442.0000 | 61,679,800 | 9.17% | 0.01% |
| Nov. 15, 2023 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Hudson Frederick M. | Director | S | Common Stock | 5211 | $28.50 | 33,231.0000 | 61,679,800 | 13.56% | 0.01% |
| Feb. 23, 2023 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Hudson Frederick M. | Director | A | Director Stock Option (Right to Buy) | 6293 | $0.00 | 6,293.0000 | 61,679,800 | 9999.99% | 0.01% |
| Feb. 23, 2023 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Hudson Frederick M. | Director | A | Restricted Stock Units | 3886 | $0.00 | 3,886.0000 | 61,679,800 | 9999.99% | 0.01% |
| Feb. 22, 2023 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Hudson Frederick M. | Director | A | Common Stock | 3882 | $0.00 | 34,867.0000 | 61,679,800 | 12.53% | 0.01% |
| Feb. 22, 2023 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Hudson Frederick M. | Director | D | Restricted Stock Units | 3882 | $0.00 | 0.0000 | 61,679,800 | 100.00% | 0.01% |
| Jan. 10, 2023 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Hudson Frederick M. | Director | M | Director Stock Option (Right to Buy) | 8722 | $0.00 | 0.0000 | 61,679,800 | 100.00% | 0.01% |
| Jan. 10, 2023 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Hudson Frederick M. | Director | M | Common Stock | 8722 | $7.90 | 30,985.0000 | 61,679,800 | 39.18% | 0.01% |